CTRI/2009/091/000794已完成3 期
Comparative, Randomized, Open Label, Parallel, Multicentric Study for Efficacy and Safety of Lornoxicam+ Eperisone versus Lornoxicam in Management of Cervical Spondylosis.
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 230
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •a) Male or female patients
- •b) Between 20-65 years of age
- •c) Willing to give written informed consent and willing to comply with trial protocol.
- •d) Out patients with diagnosis of cervical spondylosis.
- •e) Patients with at least 40 mm pain rating on VAS scale.
- •f) Patient and / or physician?s global assessment of arthritic condition as fair, poor or very poor.
- •g) Patients not on any anti-inflammatory or other therapy in the past 2 weeks known to affect the study outcome.
排除标准
- •a) Pregnant and lactating women
- •b) Patients with H/O any drug allergy
- •c) Unwilling to comply with the protocol requirements
- •d) Patients with gastro-intestinal disease, peptic ulcer,
- •bleeding disorder and fecal blood loss.
- •e) Patients with cardiac, hepatic, renal dysfunction and
- •haemopoetic disorder
- •f) Patients with hypertension
- •g) Patients deemed ineligible by the investigator
研究者
相似试验
已完成
3 期
ornoxicam + Chlorzoxazone Tablets in the treatment of Acute Musculoskeletal Pain.CTRI/2010/091/000009Hetero Labs Limited240
已完成
3 期
Cefoxitin Injection in patients with Lower Respiratory Tract InfectionsCTRI/2010/091/001508Hetero Drugs Limited Plot No B-80 & 81A.P.I.E, BalanagarHyderabad-500 037A.P., India200
未知
3 期
Open Label, Randomised, Parallel Group, Multicentre, Ph III Study To Assess Efficacy, Safety & Tolerability Of Gefitinib (IRESSA) Versus Carboplatin/Paclitaxel DC As 1st-Line Treatment In Selected Patients With Stage IIIB / IV NSCLC In Asiaon-Small Cell Lung CancerJPRN-jRCT2080220259AstraZeneca
招募中
3 期
Garenoxacin Tablets in patients with Community acquired pneumoniaCTRI/2011/10/002055Hetero Labs Ltd200
已完成
2 期
Bladder Cancer Study.CTRI/2007/091/000034Cadila Pharmaceuticals Ltd122